Karmanos Cancer Institute, Aastrom Biosciences create new center for cell therapy.
The goal of the CCT is to consolidate resources to enable cell therapies to be developed and delivered to cancer patients. The CCT will begin clinical studies with the Aastrom Replicell System using cord blood-derived cells intended to provide a normal blood and immune system in leukemia patients. The CCT will also initiate a project using the Aastrom system and Dendricell cell produce to produce dendritic cell-based vaccines intended to treat cancer.
Contact: Martha Button, Institute - (313) 996-8674, or Todd Simpson, Aastrom - (734) 930-5777
|Printer friendly Cite/link Email Feedback|
|Comment:||Karmanos Cancer Institute, Aastrom Biosciences create new center for cell therapy.|
|Article Type:||Brief Article|
|Date:||Jul 13, 2001|
|Previous Article:||World Heart announces it will receive approval to market Novacor LVAS in Japan.|
|Next Article:||Fujisawa obtains worldwide rights to Aventis' MNA compound.|